HDL in innate and adaptive immunity

QR Code

HDL in innate and adaptive immunity

During infections or acute conditions high-density lipoproteins cholesterol (HDL-C) levels decrease very rapidly and HDL particles undergo profound changes in their composition and function. These changes are associated with poor prognosis following endotoxemia or sepsis and data from genetically mo...

Full description

Bibliographic Details
Main Authors:	Catapano, A., Pirillo, A., Bonacina, F., Norata, Giuseppe
Format:	Journal Article
Published:	2014
Online Access:	http://hdl.handle.net/20.500.11937/55745

Similar Items

HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

Novel concepts in HDL pharmacology
by: Remaley, A., et al.
Published: (2014)

HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)

Integrating Innate and Adaptive Immunity for Intrusion Detection
by: Tedesco, Gianni, et al.
Published: (2006)

Innate and adaptive immune evasion by dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)

Experimenting with Innate Immunity
by: Twycross, Jamie, et al.
Published: (2006)

Libtissue - Implementing Innate Immunity
by: Twycross, Jamie, et al.
Published: (2006)

Peculiarities of innate immune memory in crustaceans
by: Chen, Fei Low, et al.
Published: (2020)

Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)

Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Lim, Hui Xuan *, et al.
Published: (2019)

No compensatory relationship between the innate and adaptive immune system in wild-living European badgers
by: Sin, Yung Wa, et al.
Published: (2016)

'Towards a Conceptual Framework for Innate Immunity'
by: Twycross, Jamie, et al.
Published: (2005)

Mammalian chitotriosidase and its role in innate immunity
by: Hall, Andrew J.
Published: (2009)

'Towards a Conceptual Framework for Innate Immunity'
by: Twycross, Jamie, et al.
Published: (2005)

Innate immune recognition of Neisseria meningitidis at the nasopharynx‎
by: Albiheyri, Raed
Published: (2016)

Apolipoprotein C-III: From Pathophysiology to Pharmacology
by: Norata, Giuseppe, et al.
Published: (2015)

Impact of systemic inflammation and autoimmune diseases on apoA-i and HDL plasma levels and functions
by: Montecucco, F., et al.
Published: (2015)

Characterisation of the Innate Immune Responses of Marron (Cherax cainii)
by: Prastowo, Bambang Widyo
Published: (2017)

Stimulation of innate and adaptive immune cells with graphene oxide and reduced graphene oxide affect cancer progression
by: Yunus, Muhammad Amir, et al.
Published: (2021)

PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)

The Western Environment Reduces Innate Immune Cytokine Production in Chinese Immigrants.
by: Saiganesh, A., et al.
Published: (2017)

25-hydroxyvitamin D3 status is associated with developing adaptive and innate immune responses in the first 6 months of life
by: Jones, A., et al.
Published: (2015)

Response of cellular innate immunity to Cnidarian Pore-Forming toxins
by: Yap, Wei Yuen *, et al.
Published: (2018)

Toward understanding of rice innate immunity against Magnaporthe oryzae
by: Azizi, Parisa, et al.
Published: (2016)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bs2aqeo6am23jtskfinvc16ee7